As a professional developer and strategic exporter of pharmaceutical raw materials, finished dosage forms, biological vaccines, and high-precision medical consumables in China, Jiangxi Serum Pharma has spent nearly 10 years mastering global regulatory pathways. We navigate complex licensing setups to enable stable supply pipelines for critical health infrastructure.
Through our targeted division focusing on EAEU (Eurasian Economic Union) and GOST-R compliance standards, we support key distributors across Moscow, Saint Petersburg, Novosibirsk, and Yekaterinburg. We provide end-to-end dossier management, facilitating registration pathways with the Ministry of Health of the Russian Federation (Roszdravnadzor).
Importing medical devices and clinical products into the Russian Federation requires strict adherence to local registration protocols. The transition from the national GOST-R registration system to the unified Eurasian Economic Union (EAEU) medical device framework has introduced comprehensive safety and clinical trials criteria. Foreign manufacturers must appoint an Authorized Representative (AR) in the territory of the EAEU, compile a detailed Technical Dossier, and conduct physical trials within authorized Russian laboratories.
Our specialized regulatory affairs team handles clinical trial documentation translation, EAEU-compliant biocompatibility testing, and dossier compilation. This process reduces registration times from 18-24 months down to predictable development phases, ensuring that items like our latex Foley catheters and sterile suction tubes arrive fully certified for immediate hospital tenders.
Geopolitical shifts and structural changes have placed Chinese medical manufacturers at the center of the Russian healthcare supply chain. China's medical device industry offers significant advantages:
Russia’s vast geography spans multiple climate zones, requiring durable medical consumables. Medical components like PVC suction tubes, catheters, and vaccines must maintain structural integrity in sub-zero regional shipping corridors. Our medical consumables are manufactured using high-grade, clinical-temperature resistant raw materials. These materials remain flexible and functional in temperatures ranging from -30°C to +40°C, supporting reliable use in emergency response and remote Siberian clinical centers.
We customize high-potency nutritional and active pharmaceutical ingredient (API) pre-mixes, ensuring uniform distribution and batch-to-batch stability in finished Russian formulations.
Learn More
Our advanced molecular co-crystallization processes optimize solubility, bioavailability, and mechanical processing properties for challenging active pharmaceutical ingredients (APIs).
Learn More
Utilizing controlled bio-fermentation systems, we extract bio-identical compounds, high-purity proteins, and plant-derived therapeutic active substances at scale.
Learn More
An in-depth analysis of the shift toward plant-derived squalene in pharmaceutical emulsions and adjuvant formulations, with a focus on Russian cosmetic and clinical manufacturers.
Why Dexamethasone Sodium Phosphate remains a vital anti-inflammatory molecule, and how we optimize raw materials for localized pharmaceutical manufacturing.
Analyzing Lilly’s Foundayo™ (orforglipron) approval, its impact on peptide APIs, and manufacturing pathways for high-demand biological materials in Russia.
